Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version of the study on Mepolizumab for chronic spontaneous urticaria, with the removal of detailed exploratory study descriptions and the addition of key identifiers such as the study number and collaborators.SummaryDifference26%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 27, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference0.6%
- Check66 days agoChange DetectedThe page has been updated to reflect the completion status of a study on Mepolizumab for Chronic Spontaneous Urticaria, with new dates indicating the last update and the actual completion date. Additionally, the study's recruitment status has changed from 'Active, not recruiting' to 'Completed'.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.